T cells and B cells join to fight solid tumors, Winship study finds

Jill Barnholtz-Sloan joins Emory Winship as chief administrative officer

Jill S. Barnholtz-Sloan was appointed chief administrative officer and associate director for research administration at Winship Cancer Institute of Emory University, effective July 21.

July 18, 2025

Vol.51 No.28

Clinical Trials & Tribulations

An overlooked immune cell population may offer new direction for cell and gene therapy

Cell and gene therapies have made incredible strides over the past decade. The 2024 FDA approvals of the first T-cell receptor therapy for the treatment of metastatic synovial sarcoma and the first tumor-infiltrating lymphocyte therapy for the treatment of unresectable or metastatic melanoma mark a significant turning point for solid tumor treatment.xxx:more

Neil Iyengar joins Winship as survivorship director, co-director of Breast Oncology Program

Breast medical oncologist and cancer survivorship expert Neil M. Iyengar was appointed director of survivorship services at Winship Cancer Institute of Emory University.

July 03, 2025

Vol.51 No.26

Clinical Roundup

Targeting Pol 1 could rewire cancer cells and suppress tumor growth, Johns Hopkins study finds

Researchers at the Johns Hopkins Kimmel Cancer Center and Department of Radiation Oncology and Molecular Radiation Sciences uncovered a new tumor-suppressive response that could lead to novel therapies targeting hard-to-treat cancers.

June 20, 2025

Vol.51 No.24

Clinical Roundup

OncoHost study offers insights into resistance mechanisms in immunotherapy-treated lung cancer

A recent OncoHost study provides insight in understanding resistance to immune checkpoint inhibitors in advanced non-small cell lung cancer. Through a comprehensive bioinformatic analysis of pretreatment plasma proteomic profiles from 272 NSCLC patients, researchers identified key biological processes associated with resistance and revealed therapeutic targets that could inform future precision treatment strategies.

June 06, 2025

Vol.51 No.22

Clinical Roundup

UChicago study reveals high doses of radiation can cause growth in existing metastatic tumors

Researchers at the University of Chicago Medicine Comprehensive Cancer Center have discovered that high doses of radiation cause growth in existing metastatic tumors that weren’t directly treated with radiation.

May 16, 2025

Vol.51 No.19

T cells and B cells join to fight solid tumors, Winship study finds

YOU MAY BE INTERESTED IN

Jill Barnholtz-Sloan joins Emory Winship as chief administrative officer

An overlooked immune cell population may offer new direction for cell and gene therapy

Neil Iyengar joins Winship as survivorship director, co-director of Breast Oncology Program

Targeting Pol 1 could rewire cancer cells and suppress tumor growth, Johns Hopkins study finds

OncoHost study offers insights into resistance mechanisms in immunotherapy-treated lung cancer

UChicago study reveals high doses of radiation can cause growth in existing metastatic tumors

Renew today!

Subscriber content

Never miss an issue!

Login